US Patent 12129263 Kinase inhibitors and uses thereof
Patent 12129263 was granted and assigned to Denali Therapeutics on October, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+32 properties)
Article (+170 characters)
US Patent 12129263 Kinase inhibitors and uses thereof
Article
Patent abstract
The present disclosure relates generally to compounds and compositions, intermediates, processes for their preparation, and their use as kinase inhibitors.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Anthony A. Estrada0
Arun Thottumkara0
Brian Fox0
Cheng Hu0
Christopher R. H. Hale0
Cinzia Maria Francini0
Colin Philip Leslie0
Elena Serra0
Javier de Vicente Fidalgo0
Jianwen A. Feng0
Maksim Osipov0
Zachary K. Sweeney0
Date of Patent
October 29, 2024
0Patent Application Number
175111930
Date Filed
October 26, 2021
0Patent Primary Examiner
Find more entities like US Patent 12129263 Kinase inhibitors and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
